Applied Genetic Technologies Corporation
AGTCNASDAQHealthcare
$0.39
+$0.00(+0.00%)
Market Cap$0
P/E Ratio—
52W High$2.825
52W Low$0.2303
Applied Genetic Technologies Corporation (AGTC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
AGTC · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2022Report Date: Nov 21, 2022EPS Actual
-$0.28
Est. -$0.28 · +0.0%
Revenue
—
Fiscal Period
Q4 FY2022
FY ends December
Report Date
Nov 21, 2022
After Market Close
✓ 1-Quarter EPS Beat Streak
AGTC reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$-0.11
Rev. $0.17B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$-0.11
Rev. Est.$0.17B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q4 FY2022 | Nov 21, 2022 | -$0.28 | -$0.28 | +0.0% | — | — | — |
| ▼ Q3 FY2022 | Sep 27, 2022 | -$0.34 | -$0.36 | -5.9% | $0.00B | — | — |
| ▲ Q2 FY2022 | May 16, 2022 | -$0.43 | -$0.33 | +23.3% | — | — | — |
| ▼ Q1 FY2022 | Feb 14, 2022 | -$0.38 | -$0.45 | -18.4% | — | — | — |
| ▼ Q4 FY2021 | Nov 9, 2021 | -$0.35 | -$0.40 | -14.3% | — | — | — |
| ▲ Q3 FY2021 | Sep 23, 2021 | -$0.40 | -$0.28 | +30.0% | $0.00B | — | — |
| ▲ Q2 FY2021 | May 17, 2021 | -$0.41 | -$0.40 | +2.4% | — | — | — |
| ▼ Q1 FY2021 | Feb 11, 2021 | -$0.59 | -$0.60 | -1.7% | — | — | — |
Q4 FY2022
Nov 21, 2022
EPS Actual
-$0.28
EPS Est.
-$0.28
EPS Surpr.
+0.0%
Revenue
—
Q3 FY2022
Sep 27, 2022Miss
EPS Actual
-$0.36
EPS Est.
-$0.34
EPS Surpr.
-5.9%
Revenue
$0.00B
Q2 FY2022
May 16, 2022Beat
EPS Actual
-$0.33
EPS Est.
-$0.43
EPS Surpr.
+23.3%
Revenue
—
Q1 FY2022
Feb 14, 2022Miss
EPS Actual
-$0.45
EPS Est.
-$0.38
EPS Surpr.
-18.4%
Revenue
—
Q4 FY2021
Nov 9, 2021Miss
EPS Actual
-$0.40
EPS Est.
-$0.35
EPS Surpr.
-14.3%
Revenue
—
Q3 FY2021
Sep 23, 2021Beat
EPS Actual
-$0.28
EPS Est.
-$0.40
EPS Surpr.
+30.0%
Revenue
$0.00B
Q2 FY2021
May 17, 2021Beat
EPS Actual
-$0.40
EPS Est.
-$0.41
EPS Surpr.
+2.4%
Revenue
—
Q1 FY2021
Feb 11, 2021Miss
EPS Actual
-$0.60
EPS Est.
-$0.59
EPS Surpr.
-1.7%
Revenue
—
No analyst estimates available for AGTC.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q4 FY2022 | Nov 21, 2022 | +0.0% | $0.38 | $0.37 | -0.74% |
| ▼ Q3 FY2022 | Sep 27, 2022 | -5.9% | $0.29 | $0.30 | +5.89% |
| ▲ Q2 FY2022 | May 16, 2022 | +23.3% | $0.73 | $0.75 | +2.59% |
| ▼ Q1 FY2022 | Feb 14, 2022 | -18.4% | $2.47 | $2.45 | -0.81% |
| ▼ Q4 FY2021 | Nov 9, 2021 | -14.3% | $2.76 | $2.56 | -7.25% |
| ▲ Q3 FY2021 | Sep 23, 2021 | +30.0% | $3.32 | $3.42 | +3.01% |
| ▲ Q2 FY2021 | May 17, 2021 | +2.4% | $3.88 | $3.84 | -1.03% |
| ▼ Q1 FY2021 | Feb 11, 2021 | -1.7% | $5.15 | $5.90 | +14.56% |
Q4 FY2022-0.74%
Report Date
Nov 21, 2022
EPS Beat/Miss
+0.0%
Price Before
$0.38
Price After
$0.37
Q3 FY2022+5.89%
Report Date
Sep 27, 2022
EPS Beat/Miss
-5.9%
Price Before
$0.29
Price After
$0.30
Q2 FY2022+2.59%
Report Date
May 16, 2022
EPS Beat/Miss
+23.3%
Price Before
$0.73
Price After
$0.75
Q1 FY2022-0.81%
Report Date
Feb 14, 2022
EPS Beat/Miss
-18.4%
Price Before
$2.47
Price After
$2.45
Q4 FY2021-7.25%
Report Date
Nov 9, 2021
EPS Beat/Miss
-14.3%
Price Before
$2.76
Price After
$2.56
Q3 FY2021+3.01%
Report Date
Sep 23, 2021
EPS Beat/Miss
+30.0%
Price Before
$3.32
Price After
$3.42
Q2 FY2021-1.03%
Report Date
May 17, 2021
EPS Beat/Miss
+2.4%
Price Before
$3.88
Price After
$3.84
Q1 FY2021+14.56%
Report Date
Feb 11, 2021
EPS Beat/Miss
-1.7%
Price Before
$5.15
Price After
$5.90
Avg Beat Reaction+0.96%
Avg Miss Reaction+3.10%
Beat Rate4 / 8 quarters
Largest Move+14.56% (Q1 FY2021)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: AGTC ends December
Applied Genetic Technologies Corporation (AGTC) most recently reported earnings on November 21, 2022 for Q4 FY2022, posting EPS of $-0.28 (in line with the analyst consensus of $-0.28). The next AGTC earnings date is expected around September 1, 2026.
Each quarter, investors track AGTC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AGTC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
AGTC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
AGTC earnings · 4 questionsApplied Genetic Technologies Corporation's next earnings report is expected around September 1, 2026. AGTC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AGTC historically reports after market close (AMC).
AGTC earnings datewhen is AGTC earningsAGTC next earnings datewhen does AGTC report earningsAGTC earnings calendar
▸ Source: FMP · Applied Genetic Technologies Corporation SEC filings · US GAAP · Applied Genetic Technologies Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026